Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome components among young adult females

Results from this study demonstrate that PCSK9 correlates with some components of metabolic syndrome and central obesity in young females. Such findings support the suggestion of using PCSK9 inhibitors in the management of MetS to modify risk for development of CVD.